由CRISPR/Cas9工程设计的Bacillus subtilis底盘,用于从海洋废弃物中量身定制的基托醇糖生产
Jiayu Liang1,2,3, Tengyue Liang1,2,3, Chengjia Wei1,2,3
1University Engineering Research Center of Advanced Technologies in Medical and Biological Intelligent Manufacturing, Guangxi Medical University, Nanning, 530021, China.
Microbial cell factories
|December 14, 2025
概括
这项研究开发了一种可持续的生物工艺,使用工程 Bacillus subtilis 来将海洋废物转化为有价值的基托醇糖 (COS). 工程细菌高效地产生胆酶,为传统的化学方法提供了一个环保的替代方案.
科学领域:
- 生物技术是生物技术.
- 合成生物学 合成生物学
- 海洋生物技术 海洋生物技术
背景情况:
- 传统的生产基托醇糖 (COSs) 的方法往往会产生化学废物.
- 海洋废物中含有丰富的酸盐,是未充分利用的资源.
- 需要可持续和环保的生物工艺来生产高价值化合物.
研究的目的:
- 建立一个可持续的生物工艺,将海洋衍生的酸盐转化为有价值的酸 (COSs).
- 为了设计Bacillus subtilis作为一个细胞工厂,用于异质基托酶的生产.
- 为了优化发酵过程,实现高产量的COS生产.
主要方法:
- 通过使用CRISPR/Cas9.9删除其内源性胆酶基因 (BsCsn) 来改造Bacillus subtilis WB800N.
- 表达了来自Streptomyces coelicolor的编码子优化的GH46胆酶 (CsnA),与AprE信号融合.
- 在DO-stat控制的料批次条件下,在5L生物反应器中使用响应表面方法优化发酵过程.
主要成果:
- 获得了540.08±6.20U/mL的高细胞外CsnA活性.
- 获得了11.25U/mL·h的生产率和1682.86U/g的碳转化效率.
- 通过MALDI-TOF MS分析确认了具有定义的聚合度 (DP2-DP4) 的COSs的生产.
结论:
- 建立了一个集成的平台,将海洋废物回收回收成高价值的COS.
- 证明了Bacillus subtilis作为一个生态高效的细胞工厂用于基托桑酶的生产.
- 提供了一个有价值的框架,用于Bacillus subtilis中其他基因酶的异质表达.
更多相关视频
相关概念视频
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K


